An expert committee recommended continuation of phase-II clinical trial of Serum Institute of India's vaccine against dengue after successful phase-I interim trial in Australia. The SEC recommendations were made on May 31.
Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.